|
Per the clinic, the patient developed progressive cholesteatoma in (b)(6) 2025 (specific date not reported), resulting in a markedly enlarged mastoid cavity with the electrode lead visibly exposed within the cavity.Hearing performance was initially stable; however, the patient reported sudden hearing loss in approximately early (b)(6) 2026.Reprogramming attempts were made; however, the issue could not be resolved.Subsequently, the device was explanted on (b)(6) 2026.During surgery, the electrode placement site was cleansed, and pus was observed within the cochlea.Postoperative antibiotics (specific type, date and duration not reported) were administered to treat the infection.The patient was reimplanted with another cochlear device during the same surgery.
|